for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Shanghai Shyndec Pharmaceutical Co Ltd

600420.SS

Latest Trade

8.74CNY

Change

-0.03(-0.34%)

Volume

3,450,950

Today's Range

8.70

 - 

8.86

52 Week Range

8.07

 - 

11.71

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
8.77
Open
8.72
Volume
3,450,950
3M AVG Volume
94.99
Today's High
8.86
Today's Low
8.70
52 Week High
11.71
52 Week Low
8.07
Shares Out (MIL)
1,026.94
Market Cap (MIL)
8,954.89
Forward P/E
--
Dividend (Yield %)
1.15

Latest Developments

More

Shanghai Shyndec Pharmaceutical's 9-Mth Net Profit Down 0.4% Y/Y

Shanghai Shyndec Pharmaceutical's Prelim H1 Net Profit Down 9.3% Y/Y

Shanghai Shyndec Pharmaceutical's 2018 Net Profit Up 36.8 Percent Y/Y

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Shanghai Shyndec Pharmaceutical Co Ltd

SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.

Industry

Biotechnology & Drugs

Contact Info

No. 1320, Beijing West Road

+86.21.62510990

http://www.shyndec.com/

Executive Leadership

Bin Zhou

Chairman of the Board, General Manager

Bin Xiao

Chief Financial Officer

Dongsong Wei

Secretary of the Board, Deputy General Manager

Zhong Gong

Deputy General Manager

Zhiqun Yang

Deputy General Manager

Key Stats

Price To Earnings (TTM)
13.10
Price To Sales (TTM)
0.76
Price To Book (MRQ)
1.22
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
75.37
LT Debt To Equity (MRQ)
22.30
Return on Investment (TTM)
11.73
Return on Equity (TTM)
6.07

Latest News

Latest News

BRIEF-Shanghai Shyndec Pharma's preliminary 2016 net profit down 10.2 pct

* Says prelim 2016 net profit down 10.2 percent y/y at 474.6 million yuan ($69.05 million)

BRIEF-Shanghai Shyndec Pharmaceutical unit gets GMP certificate

* Says its unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration Bureau

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up